Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-114217
Filing Date
2016-04-14
Accepted
2016-04-14 16:33:19
Documents
1
Period of Report
2016-04-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7014
  Complete submission text file 0001209191-16-114217.txt   8521
Mailing Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129
Business Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129 646-214-0700
ZIOPHARM ONCOLOGY INC (Issuer) CIK: 0001107421 (see all company filings)

EIN.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8093 Services-Specialty Outpatient Facilities, NEC

Mailing Address 401 PLYMOUTH ROAD, SUITE 500 PLYMOUTH MEETING PA 19462
Business Address
Fowler Wyche (Reporting) CIK: 0001301268 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33038 | Film No.: 161572100